The cells transfected with the hNIS gene under the control of the tumor-specific GFAP promoter, took in radioiodine and had lower survival rates for 131I-treated U251 and U87 cells compared with the control cells (transfected with Ad-CMV-EGFP) in vitro. Here, GFAP is linked to neoplasm.